Administración de medicamentos por vía oral

Medicina Clinica

Volumn 108, Issue 11, 1997, Pages 426-435

  Delgado, Olga ^a   Puigventós, Francesc ^a   Serra, Joan ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTITHYROID AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DIGITOXIN; DIGOXIN; DIURETIC AGENT; ERGOTAMINE; ESTRAMUSTINE; GASTROINTESTINAL AGENT; IRON SALT; LEVODOPA; LITHIUM; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYTETRACYCLINE; PSYCHOTROPIC AGENT; SEX HORMONE; THEOPHYLLINE; UNINDEXED DRUG;

CHEMICALLY INDUCED DISORDER; CLINICAL PROTOCOL; DIET RESTRICTION; DRUG ADMINISTRATION; DRUG INTERACTION; EATING; ESOPHAGITIS; HUMAN; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; REVIEW; DRUG TOLERABILITY; FOOD DRUG INTERACTION; GASTROINTESTINAL TOXICITY; PATIENT INFORMATION; SIDE EFFECT;

ADMINISTRATION, ORAL; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EATING; ESOPHAGITIS; FASTING; HUMANS; PATIENT EDUCATION; PHARMACEUTICAL PREPARATIONS;

EID: 0031002596     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. a ed.). México: Ed. Panamericana, 1991; 19-48.
2. Neuvonen PJ, Kivistö KT. The clinical significance of food-drug interactions: a review. Med J Australia 1989; 150: 36-40.
3. Delgado O. Medicamentos via oral: 10 puntos a tener en cuenta. Bolleti Informatiu de la Comissió de Farmàcia i Terapèutica del Hospital Son Dureta 1994; 2: 2-5.
4. Sánchez Castilla M, Delgado Sánchez O. Efectos secundarios de los corticosteroides. Farmacia Clinica 1994; 11: 491-503.
5. Ireland A, Gear P, Colin-Jones DG, Golding PL, Ramage JK, Williams JG et al. Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers. Lancet 1984; 2: 274-276.
6. Torrecilla A, Benftez T, González L, García B. Medicamentos. ¿En ayunas o con alimentas? El Farmacéutico Hospitales 1994; 47: 32-34.
7. D'Arcy PF, Merkus FWHM. Food and drug interactions: influence of food on drug bioavailability and toxicity. Pharmacy International 1980; 12: 238-244.
8. Randle NW. Food or nutrient effects on drug absorption: a review. Hospital Pharmacy 1987; 22: 694-718.
9. Levy RH, Pitlick WH, Troupin AS, Green JR, Neal JM. Pharmacokinetics of carbamazepine in normal man. Clin Pharmacol Ther 1975; 17: 657-668.
10. Crounse RG. Human pharmacology of griseofulvin: the effects of fat intake on gastrointestinal absorption. J Invest Derm 1961; 37: 529-533.
11. Ginsburg CM, McCracken GH, Petruska M, Olsen K. Effect of feeding on bioavailability of griseofulvin in children. J Pediatr 1983; 102: 309-311.
12. Melander A, Danielson K, Schersten B, Wahlin E. Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther 1977; 22: 108-112.
13. McLean AJ, Isbister C, Bobik A, Dudley FJ. Reduction of first-pass hepatic clearance of propranolol by food. Clin Pharmacol Ther 1981; 30: 31-34.
14. Olanoff LS, Walle T, Cowart TD, Walle K, Oexmann MJ, Conradi EC. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis. Clin Pharmacol Ther 1986; 40: 408-414.
15. Gourlay GK, Plummer JL, Cherry DA, Foate JA, Cousins MJ. Influence of a high-fat meal on the absorotion of morphine from oral solutions. Clin Pharmacol Ther 1989; 46: 463-468.
16. Korttia K, Mattila MJ, Linnoila M. Prolonged recovery after diazepam sedation: the influence of food, charcoal ingestion and injection rate on the effects of intravenous diazepam. Br J Anaesth 1976; 48: 333-339.
17. Greenblatt DJ, Duhme DW, Koch-Weser JK, Smith TW. Bioavailability of digoxin tablets and elixir in the fasting and postprandial states. Clin Pharmacol Therap 1974; 16: 444-448.
18. Axelson J, Chan G, Kirsten EB, Mason WD, Lanman RC, Kerr C. Food increase the bioavailability of propafenone. Br J Clin Pharmacol 1987; 23: 735-741.
19. Bogentoft C, Carlsson I, Ekenved G, Magnusson A. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. Eur J Clin Pharmacol 1978; 14: 351-355.
20. Mojaverian P, Rocci ML, Conner DP, Abrams WB, Vlasses PH. Effects of food on the absorption of enteric-coated aspirin: correlation with gastric residence time. Clin Pharmacol Ther 1987; 41: 11-17.
21. Welling PG. Effect of food on bioavailability of drugs. Pharmacy International 1980; 1: 14-18.
22. Pilbrant A, Cederberg C. Development of an oral formulation of omeprazol. Scand J Gastroenterol 1985; 20: 113-120.
23. Ling MHM. An overview on food-drug interactions. J Pract Pharm 1988; 6: 69-88.
24. Rodin SM, Johnson BF. Pharmacokinetic Interactions with Dixogin. Clin Pharmacokin 1988; 15: 227-244.
25. Mena I, Cotzias GC. Protein intake and treatment of Parkinson's disease with levodopa. N Engl J Med 1975; 292: 181-184.
26. Welling PG, Koch PA, Lau CC, Craig WA. Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects. Antimicrob Agents Chemother 1977; 11: 462-469.
27. Brown CS, Bryant SG. Monoamine oxidase inhibitors: safety and efficacy issues. Drug Intelligence Clinical Pharmacy 1988; 22: 232-235.
28. Aslam M, Stockley IH. Interactions between curry inteligent (karela) and drug (chlorporpamide) [carta]. Lancet 1979; 1: 609.
29. McCallum RW, Prakash C, Campoli-Richards DM, Goa KL. Cisapride: a preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 1988; 36: 652-681.
30. Meyer FP, Specht H, Quednow B, Walther H. Influence of milk on the bioavailability of doxycycline-New aspects. Infection 1989; 17: 245-246.
31. Kivisto KT, Ojala-Karlsson PO, Neuvonen PJ. Inhibition of norfloxacin absorption by dairy products. Antimicrob Agents Chemother 1992; 36: 489-491.
32. Shelton MJ, O'Donnell AM, Morse GD. Didanosine. DICP. Ann Pharmacother 1992; 26: 660-670.
33. Kulhaned F, Linde OK, Meisenberg G. Precipitation of antipsychotic drugs in interaction with coffee or tea [carta]. Lancet 1979; 2: 1.130-1.131.
34. Hirsch SR. Precipitation of antipsychotic drugs in interaction with coffee or tea [carta]. Lancet 1979; 2: 1.130-1.131.
35. Amendola MA, Spera TD. Doxycycline-Induced Esophagitis. JAMA 1985; 253: 1.009-1.011.
36. Spera TD, Amendola MA. Drug-induced esophagitis [carta]. JAMA 1985; 254: 508.
37. Matthews JW. Drug-induced esophagitis [carta]. JAMA 1985; 254: 508.
38. Jost PM. Drug-induced esophagitis [carta]. JAMA 1985; 254: 508.
39. Hayes MJ, Skoutadis VA. Drug-induced esophagitis [carta]. JAMA 1985; 254: 508.
40. Wix AR, Doering PL, Hatton RC. Drug-food interaction counseling programs in teaching hospitals. Am J Hosp Pharm 1992; 49: 855-860.
41. Garabedian-Ruffalo SM, Syrja-Farber M, Lanius P, Plucinsk A. Monitoring of drug-drug and drug-food interactions. Am J Hosp Pharm 1988; 45: 1.530-1.534.
42. Poirier TI, Guidici RA. Evaluation of Drug-Food/Nutrient Interactions Microcomputer Software Programs. Hospital Pharmacy 1991; 26: 533-535, 538-540.
43. Carruthers-Czyzewski P. Understanding food-drug interactions. CPJ-RPC 1988; 11: 698-700.
44. a ed.). Vol. 2. Rockville, Maryland: The United States Pharmacopeial Convention, Inc. 1994.
45. Drugdex@ Editorial Staff. En: Gelman CR, Rumack BH, editores. Drugdex@ Information System. Micromedex, Inc. Denver, Colorado (edición caduc. 31 de agosto de 1993).
46. a ed.). American Society of Hospital Pharmacist, 1991.
47. Melander A, Stenberg P, Liedholm H, Scherstén B, Walhlin-Boll E. Food-induced reduction in bioavailability of Atenolol. Eur J Clin Pharmacol 1979; 16: 327-330.
48. Roca M, Masso J, Codina C, Ribas J, Isamat E. Guía de administración de medicamentos. Servicio de Farmacia. Hospital Clínic i Provincial de Barcelona. Barcelona: Consulta S.A., 1992.
49. ZIAC for hypertension. Med Letter Drugs Ther 1994; 36: 23-24.
50. Catálogo de Especialidades Farmacéuticas. Madrid: Consejo Oficial de Colegios Oficiales de Farmacéuticos, 1995.
51. American Hospital Formulary Service. En: McEvoy GK, editor. Drug Information. Bethesda: American Society of Hospital Pharmacists, 1991.
52. Lode H, Stahlmann R, Koeppe P. Comparative Pharmacokinetics of Cefhalexin, Cefaclor, Cefadroxil, and CGP 9000. Antimicrob Agents Chemother 1979; 16: 1-6.
53. Glynne A, Goulbourn RA, Ryden R. A human pharmacology study of cefaclor. J Antimicrob Chemother 1978; 4: 343-348.
54. a ed.). Barcelona: Hospital de Barcelona, 1991.
55. a ed.). American Medical Association, 1993.
56. Itraconazole [editorial]. Med Letter Drugs Ther 1993; 35: 7-9.
57. Lanthier PL, Morgan MY. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut 1985; 26: 415-420.
58. Puerta Fernández MC, Delgado Sánchez O. Levodopa-carbidopa de liberación retardada en la enfermedad del Parkinson. Farmacia Hospitalaria 1993; 17: 29-37.
59. Flusser D, Zylber-Katz E, Granit L, Levy M. Influence of food on the pharmacokinetics of dipyrone. Eur J Clin Pharmacol 1988; 34: 105-107.
60. Brogden RN, Heel RC, Speight TM, Avery GS. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 1978; 16: 273-301.
61. Ueno K, Kawashima S, Uemoto K, Ikada T, Miyai K, Wada K et al. Effect of food on nifedipine sustained-release preparation. DICP. Ann Pharmacother 1989; 23: 662-665.
62. Hansen CE, Christensen TR, Elley J, Hansen LB, Kragh-Sorensen P. Clinical pharmacokinetic studies of perphenazine. Br J Clin Pharm 1976; 3: 915-923.
63. Aquilonius SM, Eckernäs SA, Hartvig P. Lindström B, Osterman PO. Pharmacokinetics and oral bioavailability of pyridostigmine in man. Eur J Clin Pharmacol 1980; 18: 423-428.
64. Caritis SN, Venkataramanan R, Cotroneo M, Chiao JP. Pharmacokinetics of orally administered ritodrine. Am J Obstet Gynecol 1989; 161: 32-35.
65. a ed.). Londres: The Pharmaceutical Press, 1993.
66. Jonkman JHG. Food interactions with sustained-release Theophylline preparations: a review. Clin Pharmacokinetics 1989; 16: 162-179.
67. Goa KL, Heel RC. Zopiclone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 1986; 32: 48-65.